United States · Bill · HR
H.R. 4369 (117th)
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
Introduced
6 July 2021
Last action
20 October 2021 · Introduced
Status
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Rep. Pallone, Frank [D-NJ-6], Brett Guthrie
Subjects
Healthcare, Education
Source updated
5 December 2025
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 July 2021
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
6 July 2021
Introduced
Introduced in House
Source: IntroReferral
6 July 2021
Introduced
Introduced in House
Source: IntroReferral
7 July 2021
Referred
Referred to the Subcommittee on Health.
Source: Committee
15 July 2021
Committee
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Source: Committee
15 July 2021
Committee
Subcommittee Consideration and Mark-up Session Held.
Source: Committee
21 July 2021
Reported
Ordered to be Reported (Amended) by Voice Vote.
Source: Committee
21 July 2021
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
19 October 2021
Passed
The title of the measure was amended. Agreed to without objection.
Source: Floor
19 October 2021
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
19 October 2021
Vote
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318). (text: CR H5645-5647)
Source: Floor
19 October 2021
Vote
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318).(text: CR H5645-5647)
Source: Floor
19 October 2021
Floor
Considered under suspension of the rules. (consideration: CR H5645-5647)
Source: Floor
19 October 2021
Vote
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Source: Floor
19 October 2021
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 4369.
Source: Floor
19 October 2021
Floor
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Source: Floor
19 October 2021
Calendars
Placed on the Union Calendar, Calendar No. 111.
Source: Calendars
19 October 2021
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.
Source: Committee
19 October 2021
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.
Source: Committee
20 October 2021
Introduced
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
Votes
19 October 2021 · passed · On Motion to Suspend the Rules and Pass, as Amended · Passed · Official source
Yes 368 · No 56 · Abstain — · Absent/not voting 7
- A. FergusonYea
- A. McEachinYea
- Abigail SpanbergerYea
- Adam KinzingerYea
- Sen. Schiff, Adam B. [D-CA]Yea
- Rep. Smith, Adam [D-WA-9]Yea
- Adrian SmithYea
- Adriano EspaillatYea
Showing the first 8 recorded positions. Vote totals above are complete.
Versions
- Referred in Senate · 20 October 2021 · Official file
- Engrossed in House · 19 October 2021 · Official file
- Reported in House · 19 October 2021 · Official file
- Introduced in House · 6 July 2021 · Official file
Documents
10 official files
Referred in Senate (text)
Referred in Senate (text)
Referred in Senate · EN · 20 October 2021
Referred in Senate (PDF)
Referred in Senate · EN · 20 October 2021
Reported in House (text)
Reported in House · EN · 19 October 2021
Reported in House (PDF)
Reported in House · EN · 19 October 2021
Engrossed in House (text)
Engrossed in House · EN · 19 October 2021
Engrossed in House (PDF)
Engrossed in House · EN · 19 October 2021
Passed House
summary · EN · 19 October 2021
Introduced in House (text)
Introduced in House · EN · 6 July 2021
Introduced in House (PDF)
Introduced in House · EN · 6 July 2021
Introduced in House
summary · EN · 6 July 2021
Sponsors
- Rep. Pallone, Frank [D-NJ-6] · D · Sponsor
- Brett Guthrie · R · Sponsor
- · sshr00 · Standing
- · hsif00 · Standing
Related records
- related to ← Securing America’s Medicine Cabinet Act of 2021
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/4369
- Open data entity: https://api.congress.gov/v3/bill/117/hr/4369
- us · 117-hr-4369 · source updated 5 December 2025